Iwao Ojima received his B.S. (1968), M.S. (1970), and Ph.D. (1973) degrees from the University of Tokyo,
Japan. He joined the Sagami Institute of Chemical Research and held a position as Senior Research Fellow
until 1983. He joined the faculty at the Department of Chemistry, State University of New York at Stony
Brook first as Associate Professor (1983), was promoted to Professor (1984), Leading Professor (1991), and
then to University Distinguished Professor (1995). He served as the Department Chairman from1997 to
2003. He serves as the founding Director for the Institute of Chemical Biology and Drug Discovery
(ICB&DD) at Stony Brook from 2003. He also serves as the President of the Stony Brook University
Chapter of the National Academy of Inventors from 2015.
His research interests include organic synthesis, medicinal chemistry and chemical biology, catalytic
asymmetric synthesis, organic synthesis by means of organometallic reagents and catalysts, peptidomimetics,
-lactam chemistry, and organofluorine chemistry. He has published more than 530 papers and reviews in
leading journals and more than l60 patents granted (48 US patents), edited 10 books (SciFinder lists >1,000
publications to his credits, Google Scholar indicates h-index of 93, total citation >39,200 by March 2026),
and he has given more than 140 Plenary and Invited Lectures in international conferences and symposia by
March 2026.
He is a recipient of the Arthur C. Cope Scholar Award (1994), the E. B. Hershberg Award (for important
discovery of medicinally active substances) (2001), the ACS Award for Creative Work in Fluorine
Chemistry (2013) and the Ernest Guenther Award (in the chemistry of natural products) (2019) from the
American Chemical Society; The Chemical Society of Japan Award (for distinguished achievements) (1999)
from the Chemical Society of Japan; Outstanding Inventor Award (2002) from the Research Foundation of
the State University of New York. He was inducted into the Medicinal Chemistry Hall of Fame, American
Chemical Society (2006).
He is an elected Fellow of the J. S. Guggenheim Memorial Foundation (1995), the American Association for
the Advancement of Science (1997), The New York Academy of Sciences (2000), the American Chemical
Society (2010), National Academy of Inventors (2014) and European Academy of Sciences (2020).
He has served in various advisory committees for National Institutes of Health (National Cancer Institute,
National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences),
National Science Foundation and the U.S. Department of Energy. He has served as a member of the
Executive Committee for the Division of Organic Chemistry and the Long Range Planning Committee for
the Division of Medicinal Chemistry, American Chemical Society. He has organized and chaired numerous
international and award symposiums at the American Chemical Society National Meetings.
He has served and has been serving as Editorial Advisory Board member of Journal of Organic Chemistry,
Organometallics, Journal of Molecular Catalysis, Chemistry Letters, Anti-Cancer Agents in Medicinal
Chemistry, Current Topics in Medicinal Chemistry, Medicinal Chemistry, Letters in Drug Design &
Discovery, and Bulletin of the Chemical Society of Japan. He serves as the Senior Editor of “Future
Medicinal Chemistry” and the Chief Editor of “Frontiers in Chemistry: Organic Chemistry”.
He has granted 82 Ph.D. degrees and 44 M.S. degrees, advised 75 postdoctoral research associates/ fellows,
17 visiting scientists, 130 undergraduate research students, and 84 high school summer research students
(many of them won Westinghouse, Intel, Regeneron and Siemens Science Competitions, including Grand
Prize) by March 2026.